Company: KW
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058797
Chunk: 68

Company: Kennedy-Wilson Holdings, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 68
---
/Kennedy Wilson/ Proxy Statement 2025

#### COMPENSATION DISCUSSION AND ANALYSIS
of Compensation – Other Executive Benefits” for additional details. The amounts payable under the life insurance policies upon each NEO’s death is as follows: Mr. McMorrow: $32 million, Mr. Enbody: $3.98 million; Mr. Windisch: $4.48 million; Mr. Lee: $2.49 million; and Mr. Pegler: $9.8 million. (3) Based on the December 31, 2024 closing stock price of $9.99. (4) Continued benefits consist of group health plan benefit continuation for the NEO and the NEO’s eligible dependents (at the same coverage levels and cost to the NEO as though the Executive’s employment had not been terminated based on the NEO’s elections as of the date of termination) through the greater of (i) the remainder of the NEO’s employment term, and (ii) the 18-month anniversary of the date of termination. (5) The employment agreements provide that, in the event that any severance or change in control payments or benefits would subject the NEO to the excise tax imposed by Section 4999 of the Tax Code, then such payments or benefit will be reduced to the extent necessary so that no portion thereof shall be subject to the excise tax imposed by Section 4999 of the Tax Code, but only if, by reason of such reduction, the net after-tax benefit received by the executive will exceed the net after-tax benefit received by such NEO if no such reduction was made. EQUITY COMPENSATION PLAN INFORMATION The following table provides information as of December 31, 2024 regarding shares outstanding and available for issuance under our Second Amended and Restated 2009 Equity Participation Plan:

| Plan Category                                              |     | Number of Shares to 
 be Issued upon      
 Exercise of         
 Outstanding Stock   
 Options, Warrants   
 and Rights          |           |     |    |     | Weighted Average Price 
 of Outstanding Stock   
 Options, Warrants and  
 Rights                 |     | Number of  
 Shares     
 Available  
 for Future 
 Issuance   |   |
| Equity compensation plans approved by our stockholders(1)  |     |                     | 9,293,292 |     | -2 |     | N/A                    |     |            | — |
| Equity compensation plans not approved by our stockholders |     |                     |         — |     |